17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway

International Journal of Molecular Medicine - Tập 33 Số 3 - Trang 550-558 - 2014
Huan Wang1, Бо Лю1, Ling Zhu1, Wenjing Wang1, Zhaofei Wan1, Fangyuan Chen1, Yan Wu1, Juan Zhou1, Zuyi Yuan1
1Department of Cardiovascular Medicine, The First Affiliated Hospital of the Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Weber, 2011, Atherosclerosis: current pathogenesis and therapeutic options, Nat Med, 17, 1410, 10.1038/nm.2538

Meyer, 2006, Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling, Hypertension, 47, 1019, 10.1161/01.HYP.0000223064.62762.0b

Hodgin, 2002, Minireview: estrogen and mouse models of atherosclerosis, Endocrinology, 143, 4495, 10.1210/en.2002-220844

Kavanagh, 2009, Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys, Arterioscler Thromb Vasc Biol, 29, 1471, 10.1161/ATVBAHA.109.191825

Ribas, 2011, Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development, Proc Natl Acad Sci USA, 108, 16457, 10.1073/pnas.1104533108

Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001/jama.280.7.605

Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321

Rosenson, 2012, Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport, Circulation, 125, 1905, 10.1161/CIRCULATIONAHA.111.066589

Saeed, 2012, Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis, Arterioscler Thromb Vasc Biol, 32, 299, 10.1161/ATVBAHA.111.240101

Wang, 2007, Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo, J Clin Invest, 117, 2216, 10.1172/JCI32057

Wang, 2008, C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells, Arterioscler Thromb Vasc Biol, 28, 519, 10.1161/ATVBAHA.107.159467

Ma, 2011, Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis, Cardiovasc Res, 92, 504, 10.1093/cvr/cvr245

Allahverdian, 2012, Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation, Cardiovasc Res, 95, 165, 10.1093/cvr/cvs094

Stary, 1994, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Arterioscler Thromb, 14, 840, 10.1161/01.ATV.14.5.840

Rong, 2003, Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading, Proc Natl Acad Sci USA, 100, 13531, 10.1073/pnas.1735526100

Higashimori, 2011, Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice, Arterioscler Thromb Vasc Biol, 31, 50, 10.1161/ATVBAHA.110.210971

Ueda, 2013, Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation, Arterioscler Thromb Vasc Biol, 33, 1837, 10.1161/ATVBAHA.112.300752

Jiang, 2010, 17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression, Mol Cell Endocrinol, 315, 74, 10.1016/j.mce.2009.09.018

Jiang, 2010, 17β-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells, J Mol Endocrinol, 45, 87, 10.1677/JME-09-0166

Metz, 2012, Vascular smooth muscle cells: isolation, culture, and characterization, Methods Mol Biol, 843, 169, 10.1007/978-1-61779-523-7_16

Tsai, 2010, EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1, Cardiovasc Res, 88, 415, 10.1093/cvr/cvq226

Han, 2009, Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages, J Biol Chem, 284, 32950, 10.1074/jbc.M109.040899

Park, 2012, Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages, Int J Mol Med, 30, 1105, 10.3892/ijmm.2012.1103

Yuan, 2012, Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis, Protein Cell, 3, 173, 10.1007/s13238-012-2025-6

Rivera, 2013, Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1, Naunyn Schmiedebergs Arch Pharmacol, 386, 1081, 10.1007/s00210-013-0909-5

Xue, 2010, High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance, Cardiovasc Res, 86, 141, 10.1093/cvr/cvp388

Choi, 2009, ATP-binding cassette transporter A1 expression and apolipoprotein AI binding are impaired in intima-type arterial smooth muscle cells, Circulation, 119, 3223, 10.1161/CIRCULATIONAHA.108.841130

Klouche, 2000, Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation, Circulation, 101, 1799, 10.1161/01.CIR.101.15.1799

Nofer, 2012, Estrogens and atherosclerosis: insights from animal models and cell systems, J Mol Endocrinol, 48, R13, 10.1530/JME-11-0145

Ghosh, 2010, Macrophage cholesteryl ester mobilization and atherosclerosis, Vascul Pharmacol, 52, 1, 10.1016/j.vph.2009.10.002

Yvan-Charvet, 2010, Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses, Arterioscler Thromb Vasc Biol, 30, 139, 10.1161/ATVBAHA.108.179283

Zhao, 2010, Liver X receptor in cholesterol metabolism, J Endocrinol, 204, 233, 10.1677/JOE-09-0271

Yan, 2013, Neopterin negatively regulates expression of ABCA1 and ABCG1 by the LXRα signaling pathway in THP-1 macrophage-derived foam cells, Mol Cell Biochem, 379, 123, 10.1007/s11010-013-1634-6

Corcoran, 2011, The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu, J Mol Endocrinol, 47, 109, 10.1530/JME-10-0158

Cerda, 2013, Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women, J Steroid Biochem Mol Biol, 138, 403, 10.1016/j.jsbmb.2013.08.017

Kramer, 2002, 17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis, J Steroid Biochem Mol Biol, 81, 203, 10.1016/S0960-0760(02)00065-1

Srivastava, 2002, Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen, Mol Cell Biochem, 240, 67, 10.1023/A:1020604610873

Liang, 2013, 17β-estradiol suppresses the macrophage foam cell formation associated with SOCS3, Horm Metab Res, 45, 423, 10.1055/s-0033-1333751

Murphy, 2011, Estrogen signaling and cardiovascular disease, Circ Res, 109, 687, 10.1161/CIRCRESAHA.110.236687

Hodgin, 2001, Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe−/−mice, J Clin Invest, 107, 333, 10.1172/JCI11320

Villablanca, 2009, 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice, J Cardiovasc Transl Res, 2, 289, 10.1007/s12265-009-9103-z

Rayner, 2009, Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor beta modulation, Arterioscler Thromb Vasc Biol, 29, 1751, 10.1161/ATVBAHA.109.193656

Xing, 2007, Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation, Am J Physiol Heart Circ Physiol, 292, H2607, 10.1152/ajpheart.01107.2006